Immune Response MS vaccine stimulates Treg activity
The new data show that monthly NeuroVax injections during a one-year period increased FOXP3, a gene marker recently shown to track regulatory T-cells, and improve Treg cell functional
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.